ANDROBIOSYS, INC.

Company Information

Company Name
ANDROBIOSYS, INC.
Address
875 Ellicott St
BUFFALO, NY, 14203-1070
Phone
n/a
URL
http://www.androbiosys.com
DUNS
193493157
Number of Employees
5

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$417,991.00
3
SBIR Phase II
$999,642.00
1
STTR Phase I
$96,765.00
1
STTR Phase II
$747,553.00
1
Chart code to be here

Award List

  1. Platelet-based Nanoparticle Therapy for Prostate Cancer

    Amount: $999,642.00

    The goal of this Phase II proposal is to develop directed energy transfer methods for imaging, tissue ablation and release of therapeutic modalities targeted to the vasculature of prostate cancer. The ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. Circulating Prostate Cancer Progenitor Cell Assay Development

    Amount: $96,765.00

    This Phase I contract proposal will evaluate and identify markers associated with prostate cancer progenitor stem cells, that differentiate these cells from adult tissue stem cells and benign prostate ...

    STTR Phase I 2008 ArmyDepartment of Defense
  3. Vascular Targeting for Imaging and Treatment of Benign Prostatic Hyperplasia

    Amount: $128,052.00

    DESCRIPTION (provided by applicant): Benign Prostatic Hyperplasia/Hypertrophy is a major health problem in the United States, with one-in-three men having urologic problems. Currently available treatm ...

    SBIR Phase I 2009 Department of Health and Human Services
  4. Primary Xenografts of Human Tissue as Surrogates of Cancer In Situ

    Amount: $139,945.00

    DESCRIPTION (provided by applicant): AndroBioSys, Inc. is dedicated to the development of human tissue-based in vivo tools capable of selecting better targeted agents for clinical trials by improved p ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. PLATELET-BASED NANOPARTICLE THERAPY FOR PROSTATE CANCER

    Amount: $149,994.00

    The goal of this proposal is to develop directed energy transfer methods for imaging, tissue ablation and release of therapeutic modalities targeted to the vasculature of prostate cancer. The platform ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. Circulating Prostate Cancer Progenitor Cell Assay Development

    Amount: $747,553.00

    The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cel ...

    STTR Phase II 2011 ArmyDepartment of Defense

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government